Unique ID issued by UMIN | UMIN000039598 |
---|---|
Receipt number | R000045156 |
Scientific Title | Effect of roxadustat on renal anemia in hemodialysis patients |
Date of disclosure of the study information | 2020/02/25 |
Last modified on | 2023/01/20 15:05:09 |
Effect of roxadustat on renal anemia in hemodialysis patients
Effect of roxadustat on renal anemia
Effect of roxadustat on renal anemia in hemodialysis patients
Effect of roxadustat on renal anemia
Japan |
End-stage renal disease
Nephrology |
Others
NO
To investigate the effect of roxadustat on renal anemia in hemodialysis patients
Safety,Efficacy
Hemoglobin concentration, serum iron, transferrin saturation, serum ferritin, hepcidin
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Roxadustat tablets are orally administered each time at the start of dialysis. The dose of roxadustat tablet is appropriately increased or decreased depending on the blood hemoglobin concentration.
20 | years-old | <= |
90 | years-old | >= |
Male and Female
Maintenance dialysis patients receiving darbepoetin more than 40 microgram per week for treatment of renal anemia
Patients complicated with serious diseases such as malignancy, heart failure (NYHA III degrees or more), and liver cirrhosis
20
1st name | Michio |
Middle name | |
Last name | Kuwahara |
Saitama Tsukinomori Clinic
Division of Nephrology
339-0012
366-1 Mashinaga, Iwatsuki-ku, Saitama city, Saitama 339-0012, Japan
0487921811
kuwahara@k-naika-cl.jp
1st name | Michio |
Middle name | |
Last name | Kuwahara |
Saitama Tsukinomori Clinic
Division of Nephrology
339-0012
366-1 Mashinaga, Iwatsuki-ku, Saitama city, Saitama 339-0012, Japan
0487921811
kuwahara@k-naika-cl.jp
Saitama Tsukinomori Clinic
Saitama Tsukinomori Clinic
Self funding
The Ethics Committee of Saitama Tsukinomori Clinic
366-1 Mashinaga, Iwatsuki-ku, Saitama city, Saitama 339-0012, Japan
0487921811
hayama@k-naika-cl.jp
NO
2020 | Year | 02 | Month | 25 | Day |
Unpublished
18
Roxadustat (median 100 mg/HD) could maintain Hb in dialysis patients treated with high-dose darbepoetin (mean dose 54 maicrogram/wk) for 1 year.
2023 | Year | 01 | Month | 20 | Day |
Completed
2020 | Year | 02 | Month | 25 | Day |
2020 | Year | 02 | Month | 25 | Day |
2022 | Year | 02 | Month | 25 | Day |
2022 | Year | 10 | Month | 31 | Day |
2022 | Year | 12 | Month | 15 | Day |
2022 | Year | 12 | Month | 15 | Day |
2022 | Year | 12 | Month | 31 | Day |
2020 | Year | 02 | Month | 25 | Day |
2023 | Year | 01 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045156
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |